Devices & Diagnostics

ZOLL gets FDA ok for military defibrillator

ZOLL Medical Corp. receives 510(K) clearance for specially designed Propaq MD Monitor/Defibrillator to be used specifically by the military. ZOLL Medical Corp. (NSDQ:ZOLL) is in the army now, having received 510(K) clearance from the U.S. Food & Drug Administration for a Propaq MD Monitor/Defibrillator designed specifically for use by the military. The announcement comes days […]

ZOLL Medical Corp. receives 510(K) clearance for specially designed Propaq MD Monitor/Defibrillator to be used specifically by the military.

ZOLL Medical Corp. (NSDQ:ZOLL) is in the army now, having received 510(K) clearance from the U.S. Food & Drug Administration for a Propaq MD Monitor/Defibrillator designed specifically for use by the military.

The announcement comes days after the Billerica, Mass.-based resuscitation products maker announced last week that its military business was down significantly in the third quarter.

Zoll reported revenues of $111.3 million in its third quarter, compared with $95 million during the same period last year, a 17 percent increase overall. However, the company’s hospital division, which includes military contracts, contracted 8 percent during the quarter based on a lack of orders from the armed forces.

Company officials were predictably bullish on news of the FDA clearance.

“The approval of this product marks a milestone for ZOLL in terms of expansion of business opportunities with military organizations around the world,” said ZOLL President Jonathan Rennert in a prepared statement.

Officials said the monitor was a joint project with the U.S. Dept. of Defense and facilitated by grants from the U.S. Army Medical Research and Development Command.

The Massachusetts Medical Devices Journal is the online journal of the medical devices industry in the Commonwealth and New England, providing day-to-day coverage of the devices that save lives, the people behind them, and the burgeoning trends and developments within the industry.

This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.